Cathie Wood Continues To Sell Tesla Shares Amid Q2 Deliveries-Induced Strength: Here's How Much Shares Ark Offloaded Monday

Zinger Key Points
  • Ark has been a net buyer of Tesla stock this year, with a tally of 1.193M stock purchases compared to 905,679 sales.
  • Ark Invest expects the stock to rally to $2,000 by 2027, premised mainly on the robotaxi service
  • The firm also bought 3.,3 million shares of CRISPR, a gene-editing company, on Monday.

Tesla. Inc. TSLA rallied over 6% in Monday's truncated session as traders bid up the stock following its stellar second-quarter deliveries.

What Happened: Cathie Wood's Ark Invest, through its Ark Innovation ETF ARKK and Ark Next Generation Internet ETF ARKW, sold 29,297 shares of Tesla. The sale is valued at $8.20 million shares based on the $279.82 at which the stock closed on Monday.

Despite the recent selling spree, Ark has been a net buyer of Tesla stock this year. As opposed to the 1.193 billion stock the firm purchased this year, it has sold 905,679 shares.

Tesla is the top of holding of ARKK, Ark's flagship exchange-traded fund, with a weighting of 11.63%. It is also the top holding of Ark Autonomous Technology & Robotics ETF ARKQ with a 14.63% weighting. The stock is the second-biggest holding of ARKW with a 7.46% weighting.

See Also: Everything You Need To Know About Tesla Stock

Why It's Important: Despite some analysts being uneasy over Tesla's valuation, given the recent run-up, almost all on the sell-side are convinced about the company's long-term potential. Wood's Ark Invest expects the stock to rally to $2,000 by 2027, with much of the upside likely coming from the yet-to-be-launched robotaxi service.

Following the second-quarter deliveries report, a slew of analysts raised the price targets for the stock. Goldman Sachs' Mark Delaney increased the price target from $248 to $275.

Other Major Ark Trades: On Monday, Ark through ARKK and ARKQ bought 69,766 shares of PagerDuty, Inc. PD valued at $1.57 million. PagerDuty is a digital operations management platform.

Other trades are as follows:

Crispr Therapeutics, Inc. CRSP: 59,148 shares, valued at $3.3 million

Verve Therapeutics, Inc. VERV: 5,025, valued at $97,824

Materialise NV MTLS: 29,899, valued at $256,832

Quantum-Si incorporated QSI: 61,088, valued at $111,180

Tesla closed Monday's session up 6.90% at $279.82, according to Benzinga Pro data.

Check out more of Benzinga’s Future Of Mobility coverage by following this link.

Read Next: Tesla’s Blockbuster Q2 Deliveries: Gene Munster Shares 5 Takeaways — And Why He Rules Out Margin Recovery In June Quarter

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!